Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Alpha Tau Medical Ltd ( (DRTS) ).
On June 17, 2025, Alpha Tau Medical Ltd. held its Annual General Meeting of Shareholders in Jerusalem, where several key proposals were approved. These included the re-election and election of directors, issuance of warrants for shares under a strategic agreement with Oramed Ltd., re-appointment of their independent accounting firm, and amendments to the Non-Employee Director Compensation Package. These approvals are expected to strengthen the company’s governance and strategic partnerships, potentially enhancing its market position and operational efficiency.
The most recent analyst rating on (DRTS) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Alpha Tau Medical Ltd stock, see the DRTS Stock Forecast page.
Spark’s Take on DRTS Stock
According to Spark, TipRanks’ AI Analyst, DRTS is a Underperform.
Alpha Tau Medical Ltd is struggling with significant financial challenges, primarily due to a lack of revenue and ongoing cash burn. While technical indicators show a neutral trend, the valuation metrics reflect the company’s unprofitability. The absence of earnings call insights and corporate events limits additional context. Overall, the stock is risky with a low score of 38, suggesting caution for potential investors.
To see Spark’s full report on DRTS stock, click here.
More about Alpha Tau Medical Ltd
Alpha Tau Medical Ltd. operates in the medical technology industry, focusing on innovative cancer treatment solutions. The company is known for its development of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), a novel approach to cancer treatment.
Average Trading Volume: 41,943
Technical Sentiment Signal: Buy
Current Market Cap: $253.8M
For detailed information about DRTS stock, go to TipRanks’ Stock Analysis page.